Evidence map›Paper›PMID 26019684›Full record

ArticleInternational journal of medical sciences2015

PIK3CA Amplification Is Common in Left Side-Tubular Adenomas but Uncommon Sessile Serrated Adenomas Exclusively with KRAS Mutation.

Hyunsu Lee, Jae-Ho Lee, Dae-Kwang Kim, In-Jang Choi, Ilseon Hwang, Yu-Na Kang, Shin Kim

Open access · goldAbstract read
In one paragraph

Article in International journal of medical sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Signaling pathways and targeted interventions for precancers.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Evolving pathologic concepts of serrated lesions of the colorectum.Journal of pathology and translational medicine · 2020
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Hyunsu Lee1. Department of Anatomy, Keimyung University School of Medicine;
Jae-Ho Lee1. Department of Anatomy, Keimyung University School of Medicine;
Dae-Kwang Kim2. Department of Medical Genetics, Keimyung University School of Medicine; ; 3. Hanvit Institute for Medical Genetics;
In-Jang Choi1. Department of Anatomy, Keimyung University School of Medicine;
Ilseon Hwang4. Department of Pathology, Keimyung University School of Medicine;
Yu-Na Kang4. Department of Pathology, Keimyung University School of Medicine;
Shin Kim5. Department of Immunology, Keimyung University School of Medicine, 2800, Dalgubeoldaero, Dalseo-Gu, Daegu, Republic of Korea.
Keimyung University · KRKeimyung College University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer is a heterogeneous disorder than arises via multiple distinct pathways, from tubular adenomas (TAs) and sessile serrated adenomas (SSAs), which are clinically, morphologically, and molecularly different. We examined PIK3CA amplification in colorectal precancerous legions, including TAs and SSAs. DNA was isolated from paired normal and tumoral tissues in 64 TAs and 32 SSAs. PIK3CA amplification, KRAS mutation, and BRAF mutation were analyzed by real-time PCR and pyrosequencing. PIK3CA amplification was found in 25% of TAs and 9.4% of SSAs, respectively. KRAS and BRAF mutations were mutually exclusive in both TAs and SSAs. In TAs, PIK3CA amplification was associated with left side and it was mutually exclusive with KRAS mutation. These results suggest that PIK3CA amplification may be early and important event in colorectal carcinogenesis and may drive the development of left-side TAs independently with KRAS mutation.

Indexed as

Gene AmplificationMutationAdenomaAgedBiomarkers, TumorCarcinogenesisClass I Phosphatidylinositol 3-KinasesColorectal NeoplasmsFemaleHumansMaleMiddle AgedPhosphatidylinositol 3-KinasesPrecancerous ConditionsProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)Biomarkers, TumorBRAF protein, humanClass I Phosphatidylinositol 3-KinasesKRAS protein, humanPhosphatidylinositol 3-KinasesPIK3CA protein, humanProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)colorectal cancermitochondriapolymorphismsessile serrated adenomastubular adenomas

Identifiers

PMID26019684
PMCPMC4445015
OpenAlexW2149931129

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.